Because the trial results came out today and they weren't as good as people expected. Had the specificity and sensitivity showed numbers above 90% as had been seen in previous studies, those same people would've probably been able to sell in the 40s today.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.